Was the "Critical Evidence" presented in the South Korean Official Cheonan Report Fabricated?
Abstract
South Korean Joint Investigation Group (JIG) [1] presented two "critical scientific evidence" that link the sinking of the South Korean navy corvette Cheonan on March 26, 2010 to the alleged explosion of a North Korean torpedo: the now-infamous "No. 1" blue ink mark on the torpedo, and the electron-dispersive spectroscopy (EDS) and x-ray data of the three "adsorbed materials" extracted from the ship, the torpedo and a small-scale test-explosion. In our previous paper [2], we described the inconsistency of JIG's EDS and x-ray diffraction (XRD) data. Here we report our SEM, EDS, and x-ray experiments on an Al powder that underwent melting followed by rapid quenching, and our simulation of the EDS spectra of Al2O3 and Al(OH)3. We obtained an experimental value of 0.25 for the EDS intensity ratio, I(O)/I(Al), and a simulation result of I(O)/I(Al) ~ 0.23 for Al2O3 formed on the surface of the adsorbed materials during an explosion. The JIG's EDS data, however, showed very different values of ~ 0.9 for the same ratio. Interestingly, the high value of ~ 0.9 is expected for "rusted" aluminum, such as Al(OH)3, that can be formed by exposing Al to moisture or water. Our results indicate that the JIG's adsorbed materials taken from the ship and torpedo are not associated with any explosion, and that the JIG's EDS data of their test-explosion sample are most likely fabricated. Until the South Korean Joint Investigation Group (JIG) can convince the international scientific communities…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.